Gastric and Oesophageal cancer: Causes and Treatment By Hannah Kerfoot Gastric (stomach) cancer and oesophageal cancers are not the most common cancers (accounting for only 2% each of all new cancer cases in the UK), however these cancers are classed as being less...
Liver cancer: what do you need to know? By Hannah Kerfoot & Pasha Yuen Liver cancer is classed as one of the least survivable cancers, with a survival rate in the UK of only 8% for 10 years or more. Although liver cancer is uncommon in the UK, being only the 17th most...
The Windsor Framework By Hannah Kerfoot Urgent reminder of the Windsor Framework: the deadline is approaching! This is especially important for all medicines manufacturers with a current PLNI and PLGB licence. They need to urgently to cancel their PLNI to be...
How can Pharmora help to commercialise your product? (Part 1) By Dr Stephanie-Jayne Jones Why do you need Pharmora? Medicines development background When a manufacturer discovers a new medicinal product there is a long process of development before it reaches patients...
The importance of reporting adverse events By Elizabeth Iwuamadi During Med Safety Week, we reflect on the importance of reporting adverse eventsReporting adverse events is fundamental in identifying potential safety issues or any associated risk in drug and supports...
What is the summary of product characteristics and how does it help me? By Dr Stephanie Pinches What is the SmPC and how does it differ from the PIL?Most people know that there is a piece of paper included with every medicine, the Patient Information Leaflet (PIL) or...
